Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYCLOPHARM LIMITED Major Shareholding Notification 2021

May 3, 2021

64741_rns_2021-05-03_fe759563-aefc-4d3d-a700-e46f692334ca.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Form 605

Corporations Act 2001 Section 671B

Notice of ceasing to be a substantial holder

To Company Name/Scheme CYCLOPHARM LIMITED

ACN/ARSN 116 931 250

1. Details of substantial holder (1)

Name Mitsubishi UFJ Financial Group, Inc. ACN/ARSN (if applicable) Not Applicable

The holder ceased to be a substantial holder on 27 April 2021 The previous notice was given to the company on 20 April 2021 The previous notice was dated 20 April 2021 The holder became aware on 30 April 2021

2. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Date of change Person whose relevant
interest changed
Nature of change (4) Consideration
given in relation
to change (5)
Class (6) and number of
Securities affected
Person’s votes
affected
19/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Collateral Returned by an
entity controlled by Morgan
Stanley–seeAnnexureA
N/A 97,687Ordinary Shares 97,687
20/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Collateral Received by an
entity controlled by Morgan
Stanley–seeAnnexureA
N/A 97,687Ordinary Shares 97,687
22/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Purchase of securities by an
entity controlled by Morgan
Stanley
159.34 62Ordinary Shares 62
23/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Purchase of securities by an
entity controlled by Morgan
Stanley
135.15 53 Ordinary Shares 53
26/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Purchase of securities by an
entity controlled by Morgan
Stanley
40.16 16 Ordinary Shares 16
26/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Purchase of securities by an
entity controlled by Morgan
Stanley
7.65 3 Ordinary Shares 3
26/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Purchase of securities by an
entity controlled by Morgan
Stanley
5.04 2Ordinary Shares 2
26/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Purchase of securities by an
entity controlled by Morgan
Stanley
20.56 8 Ordinary Shares 8
26/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Purchase of securities by an
entity controlled by Morgan
Stanley
5.08 2Ordinary Shares 2
26/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Purchase of securities by an
entity controlled by Morgan
Stanley
2.53 1Ordinary Shares 1
27/04/2021 Mitsubishi UFJ Financial
Group,Inc.
Collateral Returned by an
entity controlled by Morgan
Stanley–seeAnnexureA
N/A 1,854,955 Ordinary Shares 1,854,955

1

3. Changes in association

The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

n to voting interests in the company or scheme are as follows:
Name and ACN/ARSN(if applicable) Nature of association
Not Applicable Not Applicable

4. Addresses

The addresses of persons named in this form are as follows:

ddresses of persons named in this form are as follows:
Name Address
Mitsubishi UFJ Financial Group, Inc. 2-7-1, Marunouchi, Chiyoda-ku, Tokyo 100-8330, Japan

Signature

print name capacity Authorised signatory
sign here date 4 May 2021

2

Annexure A

This is annexure A of 1 page referred to in Form 605, Notice of ceasing to be a substantial holder dated 4 May 2021

==> picture [126 x 32] intentionally omitted <==

Authorised signatory Dated 4 May 2021

The below schedules are based on the relevant standard agreements. The entity filing the report will, if requested by the company or responsible entity to whom the prescribed form must be given or ASIC, give a copy of the agreement to the company, responsible entity or ASIC.

Schedule
Type of Agreement International Prime Brokerage Agreement
Parties to agreement Morgan Stanley & Co. International plc for itself and as agent and
trustee for and on behalf of the other Morgan Stanley Companies
and KARST PEAK THYLACINE MASTER FUND
Transfer Date 20210427;
Holder of Voting Rights Prime broker has the right to vote securities rehypothecated from
the Client.
Are there any restrictions on voting rights? ~~Yes/N~~o
Ifyes, detailNot applicable
Scheduled Return Date (if any) Open
**Does the borrower have the right to return early? ** Yes~~/No~~
Ifyes, detailPrime broker mayreturn shares which were rehypothecated from the client at anytime.
**Does the lender have the right to recall early? ** Yes~~/No~~
If yes, detailPrime broker will be required to return to the client shares rehypothecated from the client's account upon a sale of those
shares by the client.
Will the securities be returned on settlement? Yes~~/No~~
If yes, detail any exceptionsUpon an Event of Default, the default market value of all Equivalent Securities to be delivered will be
determined and on the basis of the amounts so established, an account shall be taken of what is due from each party to the other. The
amounts due from one party shall be set off against the amounts due from the other party and only the balance of the account shall
be payable.

3